Tocqueville Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Tocqueville Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-108,000	Closed	-$1.09M	–	801
2017 Q1	$1.09M	Buy	108,000 +30,000	+38%	+$446K	0.01%	486
2016 Q4	$1.21M	Buy	78,000 +27,100	+53%	+$450K	0.02%	471
2016 Q3	$980K	Sell	50,900 -1,000	-2%	-$11.9K	0.01%	509
2016 Q2	$615K	Buy	51,900 +8,000	+18%	+$132K	0.01%	590
2016 Q1	$797K	Sell	43,900 -11,900	-21%	-$216K	0.01%	537
2015 Q4	$1.53M	Buy	55,800 +5,800	+12%	+$122K	0.02%	460
2015 Q3	$1.11M	Buy	50,000 +29,000	+138%	+$524K	0.01%	540
2015 Q2	$375K	Buy	+21,000	New	+$363K	﹤0.01%	782

Other funds holding COLL

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

RSCM

Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return

TGHSA

TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

HCMT

Highland Capital Management (Texas) Dallas, Texas $39M AUM

Tocqueville Asset Management's COLL Position: Q2 2017 in Review

Tocqueville Asset Management sold out of Collegium Pharmaceutical (COLL) in Q2 2017, closing a stake of 108,000 shares — an estimated $1.09M sold.

Tocqueville Asset Management first reported a position in COLL in Q2 2015 and held it in 8 quarters. The position peaked at $1.53M in Q4 2015. 72 funds tracked by Wall St. Rank hold COLL as of Q2 2017.

Tocqueville Asset Management reported no remaining Collegium Pharmaceutical position as of Q2 2017 after selling out during the quarter.
Tocqueville Asset Management sold 108,000 Collegium Pharmaceutical shares in Q2 2017, an estimated $1.09M.
Tocqueville Asset Management first reported a position in Collegium Pharmaceutical in Q2 2015 and held it in 8 quarters.
Tocqueville Asset Management's Collegium Pharmaceutical position peaked at $1.53M in Q4 2015.
72 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2017.

Based on Tocqueville Asset Management's 13F filing for Q2 2017, filed 4 Aug 2017.